National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N05AX08	RISPERDAL	B	Risperidone - 1mg/ml	1mg/ml	Solution	1,377,439 L.L
N05AX08	RISPERDAL	B	Risperidone - 1mg/ml	1mg/ml	Solution	1,377,439 L.L
R01AB08	RINOFLUIMUCIL	B	Acetylcysteine - 1%, Tuaminoheptane sulfate - 0.5%, Benzalkonium chloride - 0.0125%		Solution	419,279 L.L
R01AD08	RINISONA	G	Fluticasone propionate - 50mcg/actuation	50mcg/dose	Spray, suspension	556,351 L.L
R01AD11	RINEX	G	Triamcinolone acetonide - 55mcg/actuation	55mcg/actuation	Spray, suspension	470,985 L.L
J07BH01	ROTATEQ ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT	B	Rotavirus G1, live attenuated - ?2.2x106 IU, Rotavirus G2, live attenuated - ?2.8x106 IU, Rotavirus G3, live attenuated - ?2.2x106 IU, Rotavirus G4, live attenuated - ?2.0x106 IU, Rotavirus P1, live attenuated - ?2.3x106 IU		Suspension	4,508,592 L.L
J07BH01	ROTARIX ORAL	B	Rota virus human RIX4414, live attenuated - ?106 CCID50		Suspension	5,167,074 L.L
J07BH01	ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL FREEZE-DRIED)	BioTech	Rotavirus bovine-human , live attenuated -		Suspension	2,822,069 L.L
R05DB13	RAPICOD	G	Butamirate citrate - 0.15%	0.15%	Syrup	296,989 L.L
R06AX27	RINA	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Syrup	159,917 L.L
C09AA05	RAMIPRIL-REMEDICA	G	Ramipril - 10mg	10mg	Tablet	896,343 L.L
N02CC04	RIZATRIPTAN ARROW	G	Rizatriptan - 10mg	10mg	Tablet	1,182,581 L.L
M01AB05	REMETHAN	G	Diclofenac sodium - 50mg	50mg	Tablet	196,201 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 2mg	2mg	Tablet	831,839 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 0.5mg	0.5mg	Tablet	831,839 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 1mg	1mg	Tablet	831,839 L.L
G04BE08	RAVANA	G	Tadalafil - 20mg	20mg	Tablet	500,421 L.L
P01AB01	RAMAZOL	G	Metronidazole - 500mg	500mg	Tablet	216,359 L.L
G04BE08	RAVANA	G	Tadalafil - 5mg	5mg	Tablet	1,501,264 L.L
C10AA07	ROVASTIN	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet	560,574 L.L
C10AA07	ROVASTIN	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet	560,574 L.L
L04AA10	RAPAMUNE	B	Sirolimus - 1mg	1mg	Tablet	12,907,489 L.L
L04AA10	RAPAMUNE	B	Sirolimus - 1mg	1mg	Tablet	L.L
R06AX28	RUPATADINE BIOGARAN	G	Rupatadine - 10mg	10mg	Tablet	341,336 L.L
N04BD02	RASAGILINE BIOGARAN	G	Rasagiline - 1mg	1mg	Tablet	5,214,109 L.L
N04BD02	RAZYLECT 1	G	Rasagiline mesylate - 1mg	1mg	Tablet	3,532,514 L.L
N04BD02	RAZYLECT 0.5	G	Rasagiline mesylate - 0.5mg	0.5mg	Tablet	2,036,369 L.L
N06BA04	RITALIN	B	Methylphenidate HCl - 10mg	10mg	Tablet	376,276 L.L
M02AA31	ROXONIN	B	Loxoprofen (Sodium) - 60mg	60mg	Tablet	788,836 L.L
M02AA31	ROXONIN	B	Loxoprofen (Sodium) - 60mg	60mg	Tablet	1,295,464 L.L